An Overview of Antiviral Peptides and Rational Biodesign Considerations.

Autor: Lee YJ; Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA., Shirkey JD; Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA., Park J; Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA., Bisht K; Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA., Cowan AJ; Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA.
Jazyk: angličtina
Zdroj: Biodesign research [Biodes Res] 2022 May 17; Vol. 2022, pp. 9898241. Date of Electronic Publication: 2022 May 17 (Print Publication: 2022).
DOI: 10.34133/2022/9898241
Abstrakt: Viral diseases have contributed significantly to worldwide morbidity and mortality throughout history. Despite the existence of therapeutic treatments for many viral infections, antiviral resistance and the threat posed by novel viruses highlight the need for an increased number of effective therapeutics. In addition to small molecule drugs and biologics, antimicrobial peptides (AMPs) represent an emerging class of potential antiviral therapeutics. While AMPs have traditionally been regarded in the context of their antibacterial activities, many AMPs are now known to be antiviral. These antiviral peptides (AVPs) have been shown to target and perturb viral membrane envelopes and inhibit various stages of the viral life cycle, from preattachment inhibition through viral release from infected host cells. Rational design of AMPs has also proven effective in identifying highly active and specific peptides and can aid in the discovery of lead peptides with high therapeutic selectivity. In this review, we highlight AVPs with strong antiviral activity largely curated from a publicly available AMP database. We then compile the sequences present in our AVP database to generate structural predictions of generic AVP motifs. Finally, we cover the rational design approaches available for AVPs taking into account approaches currently used for the rational design of AMPs.
Competing Interests: The authors declare that there is no conflict of interest regarding the publication of this article.
(Copyright © 2022 Ying-Chiang J. Lee et al.)
Databáze: MEDLINE